🇺🇸 FDA
Patent

US 10464970

Compounds that bind to human immunodeficiency virus rev response element

granted A61KA61K38/00A61K38/17

Quick answer

US patent 10464970 (Compounds that bind to human immunodeficiency virus rev response element) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K38/17, A61K45/06, A61K47/64